COGT Operating Cash Flow (Statement)
Cogent Biosciences Inc · Operating Cash Flow (Statement)
COGT Operating Cash Flow (Statement)
Latest reported-$307.55Mperiod ending
COGT TTM Cash from Operations (-$25.84M → -$307.55M)
TTM operating cash flow (statement)
High-resolution chart · PNG
COGT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -307,545,000 | |
| -284,816,000 | |
| -264,444,000 | |
| -245,916,000 | |
| -233,614,000 | |
| -221,773,000 | |
| -207,791,000 | |
| -191,284,000 | |
| -177,271,000 | |
| -166,636,000 | |
| -153,624,000 | |
| -138,962,000 | |
| -135,431,000 | |
| -129,821,000 | |
| -118,638,000 | |
| -110,007,000 | |
| -89,676,000 | |
| -75,731,000 | |
| -58,763,000 | |
| -47,352,000 | |
| -43,510,000 | |
| -39,323,000 | |
| -35,850,000 | |
| -34,929,000 | |
| -34,869,000 | |
| -37,889,000 | |
| -41,514,000 | |
| -42,089,000 | |
| -39,457,000 | |
| -36,026,000 | |
| -32,489,000 | |
| -29,985,000 | |
| -28,700,000 | |
| -26,548,000 | |
| -25,835,000 | |
| -19,319,000 | |
| -13,029,000 |